• SENSEX 76,391.39
    -363.66 (--0.47%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • HDFC Bank
    743.25 726.75(%)
  • CIE Automotive
    411.35 382.20(%)
  • Oracle Fin.Serv.
    9,950.00 6,232.20(%)
  • Bluestone Jewel
    732.05 400.40(%)
  • Bharti Airtel
    1,925.60 1,745.00(%)
  • Reliance Industries
    1,268.00 1,253.65(%)
  • Bajaj Finance
    1,037.00 788.40(%)
  • Bajaj Finserv
    1,900.15 2,194.65(%)
  • Tanla Platforms
    656.70 765.75(%)
  • Maruti Suzuki
    13,371.65 12,202.10(%)
  • Gandhar Oil Ref.
    283.85 245.00(%)
  • Route Mobile
    649.90 949.80(%)
  • Eternal
    296.15 368.40(%)
  • Adani Green
    1,372.70 767.00(%)
  • Infosys
    1,032.30 984.00(%)
  • IndusInd Bank
    999.00 710.85(%)
  • SBI
    1,006.50 786.55(%)
  • Axis Bank
    1,219.05 1,041.30(%)
  • CG Power & Ind
    881.00 525.50(%)
  • SBI Funds Mgt.
    575.35 582.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Amrutanjan Health Care Ltd Pharmaceuticals - Indian - Formulations

  • Amrutanjan
  • BSE Code : 17.0
  • ISIN : INE098F01031
529.10 -10 (-1.76%)
  • As on 23 Jul 2026 (EOD)
  • Today’s Low

    526.65
  • Today’s High

    538.60
  • Open

    538.60
  • Perv Close

    538.60
  • 52W Low

    486.00
  • 52W High

    790.95

Key Indicators

  • P/E(TTM)

    23.73

  • Mar.Cap (₹Cr.)

    1,529.66

  • Div & Yield %

    0.93

  • Book Value(₹)

    128.06

  • Debt-Equity Ratio

    -1.76

  • AGM Date

    22-Jul-2026

  • EPS

    22.31

  • P/E Ratio

    23.73

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,529.66

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    2.89

  • BV (₹)

    128.10

  • Sales( ₹ in Cr.)

    502.55

  • NP (in Cr.)

    64.50

  • NP Var(%)

    27.0

  • Div%

    490.0

  • CPS (₹)

    24.50

  • EPS (₹)

    22.30

  • Traded Value (₹ in Lakhs)

    1,530.38

  • 52 Week High

    790.95

  • 52 Week Low

    486.00

  • Price BSE

    529.0

  • Price NSE

    529.00

  • Market Capital( in Cr.)

    1,530.38

  • P/C Ratio

    21.60

  • P/E Ratio

    23.70

  • Price Vs.BV

    22.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 451.82 421.23 379.64 405.84 332.84 261.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 451.82 421.23 379.64 405.84 332.84 261.48
Other Income 17.68 16.35 14.54 15.38 11.32 8.32
Stock Adjustments 0.57 -2.15 1.73 5.50 -5.01 6.97
Total Income 470.07 435.43 395.91 426.72 339.15 276.77
EXPENDITURE :            
Raw Materials 223.78 209.67 183.71 185.96 135.18 124.05
Power and Fuel Cost 3.52 3.84 3.06 2.66 1.76 2.02
Employee Cost 59.10 47.69 48.81 48.23 41.70 39.36
Other Manufacturing Expenses 10.96 9.86 10.38 8.37 6.66 6.78
Selling and Administration Expenses 92.02 89.23 86.95 84.68 64.72 61.45
Miscellaneous Expenses 4.70 6.87 3.92 1.87 2.97 3.96
Employee Benefit Expenses 59.10 47.69 48.81 48.23 41.70 39.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 394.08 367.17 336.83 331.77 252.99 237.62
Operating Profit 75.99 68.25 59.08 94.95 86.16 39.15
Interest 0.33 0.25 0.22 0.58 0.59 0.34
Gross Profit 75.66 68.00 58.86 94.37 85.57 38.81
Depreciation 6.53 6.06 5.21 3.80 3.67 4.36
Profit Before Tax 69.13 61.94 53.65 90.57 81.90 34.45
Current Tax 17.97 15.94 14.01 23.39 19.73 9.43
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.33 1.03 -0.20 0.00 0.98 -0.06
Reported Net Profit 50.83 44.97 39.83 67.19 61.19 25.08
Extraordinary Items 0.00 0.11 0.02 0.01 0.07 0.00
Adjusted Net Profit 50.83 44.86 39.81 67.18 61.12 25.08
Adjustment below Net Profit -0.79 -35.32 0.00 0.00 0.00 -0.63
P & L Balance brought forward 236.21 239.89 214.72 161.62 105.13 91.44
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.30 13.33 14.67 14.08 4.71 10.76
P & L Balance carried down 272.96 236.21 239.89 214.72 161.62 105.13
Dividend 0.00 0.00 0.00 5.85 4.68 6.14
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 460.00 460.00 460.00 460.00 420.00 210.00
Dividend Per Share(Rs) 4.60 4.60 4.60 4.60 4.20 2.10
Earnings Per Share-Unit Curr 17.58 15.56 13.63 22.99 20.93 8.58
Earnings Per Share(Adj)-Unit Curr 17.58 15.56 13.63 22.99 20.93 8.58
Book Value 112.97 99.78 99.47 90.70 73.75 54.54
Book Value(Adj)-Unit Curr 112.97 99.78 99.47 90.70 73.75 54.54

Shareholding Pattern

  • Promoter Group

    46.52%

  • Public Share Holding

    53.45%

  • Custodian

    0.04%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 10,918,703 37.77 10,918,703 4
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,529,487 8.75 2,529,487 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,448,190 46.52 13,448,190 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25,460 0.09 24,960 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 704,823 2.44 704,823 31
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,682,578 5.82 1,682,578 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,843,400 6.38 1,843,400 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,256,261 14.72 4,255,761 47
2] Non Institution
Bodies Corporate 461,785 1.60 460,265 168
Clearing Members 128 0.00 128 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 496,500 1.72 496,180 1,062
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 375,244 1.30 375,240 725
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 870,703 3.01 870,703 3
Individuals holding nominal share capital up to Rs. 1 lakh 8,398,467 29.05 8,011,151 43,095
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 6,170 0.02 6,170 1
Others 438,226 1.52 435,546 2
Sub Total 11,195,630 38.73 10,803,790 45,080
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 10,549 0.04 10,549 1
Total Shares held by Custodians and against which Depository Receipts have been issued 10,549 0.04 10,549 1
Grand Total ( A + B + C ) 28,910,630 100.00 28,518,290 45,135

Company Background

Amrutanjan Health Care LtdPharmaceuticals - Indian - Formulations

  • Amrutanjan Health Care Ltd
  • BSE Code : 17.0
  • ISIN : INE098F01031
  • Incorporation Year

    1936

  • Registered Office

    New 103 Old 42-45 LuzChurch Rd
    Mylapore, Chennai,
    Tamil Nadu-600004

  • Telephone

    91-44-24994164/24994465/24994366

  • FAX

    91-44-24994585

  • Chairman

    S Sambhuprasad

  • Managing Director

  • Company Secretary

  • Auditor

    B S R & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Amrutanjan Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Abbott India 28,898.60 7,217.19 6,929.05 39.57 43.78
Astrazeneca Phar 8,033.05 2,304.07 2,275.58 107.09 27.86
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 474.15 450.25 19.27 18.77
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77